Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.
Aged
Asian People
/ genetics
Case-Control Studies
China
/ epidemiology
Female
Gene Frequency
Genetic Predisposition to Disease
/ ethnology
Genome-Wide Association Study
Humans
Male
Microtubule-Associated Proteins
/ genetics
Middle Aged
Odds Ratio
Polymorphism, Single Nucleotide
Receptor, Fibroblast Growth Factor, Type 3
/ genetics
Risk Assessment
/ methods
Urinary Bladder Neoplasms
/ ethnology
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
21
5
2020
Statut:
ppublish
Résumé
Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) associated with bladder cancer (BCa) risk in Caucasian and East Asian population. The objective of this study was to validate these SNPs in Chinese population and evaluate whether these SNPs could differentiate the individual inherited risk for BCa.A case-control study including 581 BCa cases and 1561 healthy controls was performed. Germline DNA samples from all individuals were genotyped for eight SNPs. Genetic risk score (GRS) was calculated for each individual based on the odds ratios and risk allele frequencies of five risk-associated SNPs.Among eight SNPs evaluated in this study, rs798766 at 4p16.3 [OR = 1.39 (1.15-1.67), P < .001], rs9642880 [OR = 1.17 (1.06-1.30), P < .001] and rs4813953 at 20p12.2 [OR = 1.09 (1.02-1.17), P = .016] were found associated with BCa risk in Chinese population. A genetic risk score was established based on five SNPs (including the above three SNPs and two other SNPs which have the consistent direction with previous reported genome-wide association study). The mean GRS was significantly higher in BCa cases than controls (1.22 vs. 1.01, P < .001). When subjects were categorized into low- (<0.8), average- (0.8-1.2), and high-risk (>1.2) groups, the likelihoods of BCa were 25.2%, 33.7% and 55.0%, respectively (P-trend < 2.2 × 10). In subgroup analyses, no significant difference was observed in mean GRS among BCa patients with different stages or grades.In conclusion, two SNPs derived from East Asian and one SNP from Caucasian were associated with BCa risk in Chinese population. These results provided additional information of genetic risks for BCa in Chinese population. Genetic risk score based on these SNPs can reveal inherited risk of BCa, and may have potential for modifying personalized cancer screening strategy.
Identifiants
pubmed: 32384449
doi: 10.1097/MD.0000000000019980
pii: 00005792-202005080-00026
pmc: PMC7220229
doi:
Substances chimiques
Microtubule-Associated Proteins
0
TACC3 protein, human
0
FGFR3 protein, human
EC 2.7.10.1
Receptor, Fibroblast Growth Factor, Type 3
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19980Références
Int J Cancer. 2014 Dec 1;135(11):2653-60
pubmed: 24740636
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
J Natl Cancer Inst. 2004 Mar 17;96(6):434-42
pubmed: 15026468
Atherosclerosis. 2017 Feb;257:172-178
pubmed: 28142076
Cancer Epidemiol. 2017 Jun;48:29-35
pubmed: 28363161
Eur J Epidemiol. 2016 Sep;31(9):811-51
pubmed: 27000312
J Clin Oncol. 2006 Aug 1;24(22):3664-71
pubmed: 16877735
Circulation. 2016 Mar 22;133(12):1181-8
pubmed: 26915630
Carcinogenesis. 2011 Jun;32(6):872-5
pubmed: 21459758
Asian J Androl. 2016 Jul-Aug;18(4):509-14
pubmed: 27297129
J Natl Cancer Inst. 2018 May 1;110(5):527-533
pubmed: 29228305
Nat Genet. 2008 Nov;40(11):1307-12
pubmed: 18794855
Eur Urol. 2018 Dec;74(6):784-795
pubmed: 30268659
Hum Mol Genet. 2014 Oct 15;23(20):5545-57
pubmed: 24861552
Genet Med. 2017 Mar;19(3):322-329
pubmed: 27513194
Chin J Cancer Res. 2015 Feb;27(1):2-12
pubmed: 25717220
J Natl Cancer Inst. 2017 Jul 1;109(7):
pubmed: 28376175
Hum Mol Genet. 2014 Mar 1;23(5):1387-98
pubmed: 24163127
Eur Urol. 2008 Oct;54(4):835-43
pubmed: 18166262
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3150-6
pubmed: 21051319
Nat Genet. 2010 May;42(5):415-9
pubmed: 20348956
Curr Diab Rep. 2017 Oct 28;17(12):129
pubmed: 29080981
Cancer Prev Res (Phila). 2017 Sep;10(9):535-541
pubmed: 28729251
Cancer Med. 2019 Jun;8(6):3196-3205
pubmed: 30968590
Dis Markers. 2017;2017:7850708
pubmed: 28655970
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Urol. 2001 Dec;166(6):2129-33
pubmed: 11696721